Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Austrian Retail Association, Marinomed (29/01/2019)

03.02.2019

Austrian Retail Associations : On the 25th of January 2019, 55 leading eCommerce Associations - including the Austrian Retail Associations (Handelsverband) as representative of the Austrian retail sector - published an open letter, addressed to the trade minister of the World Trade Organization (WTO), calling for an eCommerce Framework on a global level.At the World Economic Forum in Davos, the economics- and trade Ministers of 32 Countries agreed to negotiate an international agreement for eCommerce. The negotiation process is planned to start with the end of March 2019. "We are very pleased, that our open letter had such great impact. Now it's about bringing a viable agreement down to earth, so that the digital wild west can finally become a level playing field", says Rainer Will, CEO of the Austrian Retail Association. At the WTO-Summit one year ago, the international community was unable to agree on multilateral negotiations, that's why a group of 76 WTO members, including Austria, Germany, Japan and the USA agreed to lead conversations offside the WTO. "The Austrian Retail Association will be actively involved in the negotiations and wants to ensure fair taxation for digital champions and to help small and medium-sized domestic traders to succeed in Cross Border eCommerce" - Rainer Will.

Marinomed: Marinomed Biotech AG has set the Offer Price for new shares of the company in connection with its IPO at 75 Euro per share. In total, 299,000 new bearer shares were placed with investors. These consist of 260,000 shares from the base offer and 39,000 shares due to over-allotments. Assuming full exercise of the greenshoe option, gross proceeds will amount to Euro 22.4 mn. The proceeds from the IPO shall be used primarily to fund the Pivotal Phase III study of Budesolv, Phase II and Phase III studies of Tacrosolv as well as the extension of the Carragelose® OTC platform.
Marinomed Biotech: weekly performance: 0.00%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (29/01/2019)


Partners









latest 21st Austria

21st Austria weekly - Austrian Retail Association, Marinomed (29/01/2019)


03.02.2019, 2031 Zeichen



Austrian Retail Associations : On the 25th of January 2019, 55 leading eCommerce Associations - including the Austrian Retail Associations (Handelsverband) as representative of the Austrian retail sector - published an open letter, addressed to the trade minister of the World Trade Organization (WTO), calling for an eCommerce Framework on a global level.At the World Economic Forum in Davos, the economics- and trade Ministers of 32 Countries agreed to negotiate an international agreement for eCommerce. The negotiation process is planned to start with the end of March 2019. "We are very pleased, that our open letter had such great impact. Now it's about bringing a viable agreement down to earth, so that the digital wild west can finally become a level playing field", says Rainer Will, CEO of the Austrian Retail Association. At the WTO-Summit one year ago, the international community was unable to agree on multilateral negotiations, that's why a group of 76 WTO members, including Austria, Germany, Japan and the USA agreed to lead conversations offside the WTO. "The Austrian Retail Association will be actively involved in the negotiations and wants to ensure fair taxation for digital champions and to help small and medium-sized domestic traders to succeed in Cross Border eCommerce" - Rainer Will.

Marinomed: Marinomed Biotech AG has set the Offer Price for new shares of the company in connection with its IPO at 75 Euro per share. In total, 299,000 new bearer shares were placed with investors. These consist of 260,000 shares from the base offer and 39,000 shares due to over-allotments. Assuming full exercise of the greenshoe option, gross proceeds will amount to Euro 22.4 mn. The proceeds from the IPO shall be used primarily to fund the Pivotal Phase III study of Budesolv, Phase II and Phase III studies of Tacrosolv as well as the extension of the Carragelose® OTC platform.
Marinomed Biotech: weekly performance: 0.00%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (29/01/2019)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S12/11: Patrick Kesselhut




 

Bildnachweis

Aktien auf dem Radar:Addiko Bank, Immofinanz, Wienerberger, Flughafen Wien, Warimpex, Porr, AT&S, Palfinger, Strabag, Uniqa, Verbund, Pierer Mobility, Andritz, Frequentis, S Immo, Oberbank AG Stamm, Amag, Agrana, CA Immo, Erste Group, EVN, Kapsch TrafficCom, OMV, Österreichische Post, Telekom Austria, VIG, Deutsche Bank, IBM, Caterpillar, Beiersdorf, Symrise.


Random Partner

Liechtensteinische Landesbank (Österreich) AG
Die Liechtensteinische Landesbank (Österreich) AG ist mit einem betreuten Vermögen von mehr als 22 Mrd. Euro und über 230 Mitarbeitenden (per 30.6.2019) Österreichs führende Vermögensverwaltungsbank. Die eigenständige österreichische Vollbank ist darüber hinaus auch in den Ländern Zentral- und Osteuropas, in Italien und Deutschland tätig. Als 100-prozentige Tochter der Liechtensteinischen Landesbank AG (LLB), Vaduz profitiert die LLB Österreich zusätzlich von der Stabilität und höchsten Bonität ihrer Eigentümerin.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten